Glucagon-like peptide-1 receptor (GLP-1R) agonists are increasingly recognized for their multifaceted role in improving glucose regulation, reducing appetite, and promoting weight loss, which are all critical aspects of managing GDM [338,339,340]. Here, GLP1R is linked to gestational diabetes.